Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity

Background: Doxorubicin is a widely used agent in the treatment of cancer, but the cardiotoxicity associated with this drug limits its potential for use. The cardioprotective effects of dapagliflozin, an antidiabetic drug, have the potential to counteract the cardiotoxic effect of doxorubicin therap...

Full description

Bibliographic Details

Published in:	Anatolian Journal of Cardiology
Main Authors:	Sebahat Ulusan, Kanat Gülle, Ahmet Peynirci, Murat Sevimli, Adnan Karaibrahimoglu, Mevlüt Serdar Kuyumcu
Format:	Article
Language:	English
Published:	KARE Publishing 2023-05-01
Subjects:	doxorubicin cardiotoxicity dapaglifozin
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-42888